Start a new search
Add filters:

Use filters to refine the search results.

Results 881-890 of 892
Item hits:
Issue DateTitleAuthor(s)
31-Oct-2019The 14q32 maternally imprinted locus is a major source of longitudinally stable circulating microRNAs as measured by small RNA sequencingValbuena, GN; Apostolidou, S; Roberts, R; Barnes, J; Alderton, W, et al
28-Jul-2019EP300 and SIRT1/6 co-regulate lapatinib sensitivity via modulating FOXO3-acetylation and activity in breast cancerMahmud, Z; Gomes, A; Lee, HJ; Aimjongjun, S; Jiramongkol, Y, et al
1-Sep-2019Integrated systems-genetic analyses reveal a network target for delaying glioma progressionLaaniste, L; Srivastava, P; Stylianou, T; Syed, N; Cases-Cunillera, S, et al
1-Oct-2019Studies of proteasome inhibition and apoptosis induction in triple‐negative breast cancer cells by novel amino acid–polypyridine–copper complexLi, D; Wang, L; Yagüe, E; Dai, L; Zhao, X, et al
2-Sep-2019Single-cell transcriptomics reveals multi-step adaptations to endocrine therapyHong, SP; Lombardo, Y; Chan, TE; Corleone, G; Rotmensz, N, et al
30-Nov-2019Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safetyKristeleit, RS; Oaknin, A; Ray-Coquard, I; Leary, A; Balmaña, J, et al
1-Sep-2019Surgical diabetic foot debridement: improving training and practice utilizing the traffic light principleAhluwalia, R; Vainieri, E; Tam, J; Sait, S; Sinha, A, et al
1-Jan-2019Characterization of FOXO acetylationYao, S; Mahmud, Z; Sachini, N; Aimjongjun, S; Saavedra-García, P, et al
Feb-2019BRCA reversion mutations in circulating tumor DNA predict primary and acquired resistance to the PARP inhibitor rucaparib in high-grade ovarian carcinomaLin, KK; Harrell, MI; Oza, AM; Oaknin, A; Ray-Coquard, I, et al
Aug-2019Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia.Branford, S; Kim, DDH; Apperley, JF; Eide, CA; Mustjoki, S, et al